Clinical Trials Browser

Ovarian Neoplasms

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Ovarian Neoplasms

Ovarian Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms

Uterine Cervical Neoplasms, Genital Neoplasms, Female, Ovarian Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

Ovarian Neoplasms

Ovarian Neoplasms

Breast Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, Ovarian Neoplasms, Intestinal Polyposis

Ovarian Neoplasms

Ovarian Neoplasms

Ovarian Neoplasms

Ascites, Ovarian Neoplasms

Ovarian Neoplasms

Ovarian Neoplasms

Ovarian Neoplasms

Uterine Cervical Neoplasms, Ovarian Neoplasms

Ovarian Neoplasms

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Ovarian Germ Cell Cancer, Neoplasms, Germ Cell and Embryonal, Ovarian Neoplasms

Ovarian Neoplasms

Ovarian Neoplasms

Ovarian Neoplasms

Disease, Ovarian Neoplasms

Ovarian Neoplasms

Clinical Trials

EORTC QOL-OV39

The Role of Blood Perfusion in Cervical Cancer, Cervical Intraepithelial Neoplasm and Ovarian Cancer Patients

Visual-PC

Impact of Dietary Patterns on Prognosis of Ovarian Cancer Patients During PARPi Maintenance

Contribution of Oncovascular Surgery in the Treatment of Gynecological Advanced Malignant Diseases.

PANtHer-AI

Efficacy and Safety of Sacituzumab in Patients With OCCC After Immunotherapy Progression

COSMOS

OCS Products Based on Exosome Technology Were Applied in the Recurrence Monitoring Study After the Initial Treatment of Baseline CA125-negative Ovarian Cancer

MISSION-2

Exosome-based Recurrence Score for Post-Treatment Ovarian Cancer

High Definition Profiling of Ovarian Cancer Ascites

The Role of CircDENND4C in Epithelial Ovarian Cancer

Exosome-based OCS Scores for Predicting Ovarian Cancer Recurrence

Research and Application of Ultrasonic Intelligent Diagnosis System for Ovarian Mass

The Exploration of Personalized ctDNA Based MRD in the Clinical Significance of Cervical Cancer

STICRISC

To Explore the Feasibility of Dynamic Changes of TCR Diversity in Peripheral Blood in Monitoring Recurrence and Evaluating Prognosis of Epithelial Ovarian Cancer

SUMMER

BRCA 1/2 Status as a Predictive Factor to Response to Platinum Based Chemotherapy in Cancer Ovary

The Correlation Between HRD Detection and the Efficacy of PARP Inhibitors in Ovarian Cancer

Investigating Participation Patterns Among Recurrent Ovarian Cancer Patients

The Effectiveness of Liquid Biopsy in Differential Diagnosis and Early Screening of Epithelial Ovarian Cancer

Appraising Medical Trial Experiences of Ovarian Cancer Patients